| Nov 15 |
Blueprint Medicines' Growth With AYVAKIT And Next-Gen Oncology Drugs
|
| Nov 14 |
Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst
|
| Nov 2 |
Analysts Have Made A Financial Statement On Blueprint Medicines Corporation's (NASDAQ:BPMC) Third-Quarter Report
|
| Nov 1 |
High Growth Tech Stocks to Watch in November 2024
|
| Nov 1 |
Blueprint Medicines Third Quarter 2024 Earnings: EPS Beats Expectations
|
| Oct 31 |
BPMC Beats on Q3 Earnings and Sales, Raises '24 View, Stock Up
|
| Oct 31 |
Blueprint Medicines Corp (BPMC) Q3 2024 Earnings Call Highlights: Record AYVAKIT Revenue and ...
|
| Oct 31 |
Q3 2024 Blueprint Medicines Corp Earnings Call
|
| Oct 30 |
Blueprint Medicines Corporation (BPMC) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
Blueprint Medicines (BPMC) Reports Q3 Loss, Tops Revenue Estimates
|
